Advertisement
Advertisement
CTXR
Citius Pharmaceuticals Inc. Common
0.57
USDSponsored
+0.01
+1.79%
Jun 24, 15:58 UTC -4
Closed
After-Market
0.56
-0.01
-1.40%
CTXR Earnings Reports
Positive Surprise Ratio
CTXR beat 9 of 27 last estimates.
33%
Next Report
Date of Next Report
Aug 10, 2026
Estimate for Q3 26 (Revenue/ EPS)
$15.10M
/-$0.01
Implied change from Q2 26 (Revenue/ EPS)
--
/--
Implied change from Q3 25 (Revenue/ EPS)
--
/-98.75%
Citius Pharmaceuticals Inc. Common earnings per share and revenue
On May 13, 2026, CTXR reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -0.20 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 10.07 million, with a --% difference.
Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.01 USD, with revenue projected to reach 15.10 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Citius Pharmaceuticals Inc. Common's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Citius Pharmaceuticals Inc. Common reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Citius Pharmaceuticals Inc. Common's Q2 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Citius Pharmaceuticals Inc. Common expected to report next?
The next earning report is scheduled for Aug 10, 2026.
What are the forecasts for Citius Pharmaceuticals Inc. Common's next earnings report?
Based on 3
analysts, Citius Pharmaceuticals Inc. Common is expected to report EPS of -$0.01 and revenue of $15.10M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement